- World rank, all time
- #37,348 of 42,892
- Rank in United States
- #7,877 of 8,685
- Research works
- 124 ▲ 102% vs 2013–17
- Citations
- 1.8k 14.8 per fractional work
- Top-10% rate
- 20.6% record average 16.5%
- Open access
- 30% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 11.1×. Every wedge is a field page.
- Veterinary 11.1×
- Nursing 9.2×
- Economics, Econometrics and Finance 4.4×
- Biochemistry, Genetics and Molecular Biology 2.6×
- Medicine 2.3×
- Agricultural and Biological Sciences 2.2×
- Immunology and Microbiology 1.6×
- Arts and Humanities 1.6×
- Environmental Science 1.1×
- Physics and Astronomy 0.4×
- Engineering 0.2×
- Computer Science 0.1×
Who are the top researchers at Baxalta (United States)?
Ranked on the composite score, Douglas M. Sproule, Douglas E. Feltner and James L’Italien lead among researchers whose main affiliation is Baxalta (United States).
- 1 Douglas M. Sproule United States · #335,984 worldwide 84 citations · 19 works
- 2 Douglas E. Feltner United States · #544,206 worldwide 81 citations · 27 works
- 3 James L’Italien United States · #1,131,084 worldwide 53 citations · 17 works
- 4 R. Arjunji United States · #1,396,180 worldwide 0 citations · 15 works
- 5 Omar Dabbous United States · #1,461,967 worldwide 3 citations · 38 works
- 6 Francis G. Ogrinc United States · #1,569,324 worldwide 3 citations · 16 works
Which keywords describe research at Baxalta (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Antisense Oligonucleotides, SMN1, Spinal Muscular Atrophy, Cancer Progression, m6A-seq, RNA methylation, Genetic Mutations and Gene Therapy.
- Healthcare Quality
- Rituximab
- Anemia
- Prenatal Diagnosis
- Cell Proliferation
- Primary Immunodeficiency
- Epigenetic Regulation
- Fragile X Syndrome
- Cost-effectiveness Analysis
- Immune Thrombocytopenic Purpura
- Cancer
- Factor VIII
- RNA-Guided
- Thrombosis
- Hemostasis
- Epidemiology
- Inflammation
- m6A-seq
- Cancer Progression
- SMN1
- Antisense Oligonucleotides
- Spinal Muscular Atrophy
- RNA methylation
- Genetic Mutations
- Gene Therapy
- Quality of Life
- Prophylaxis
- Genome Engineering
- Inhibitors
- Hemophilia
- Transcriptional Regulation
- Platelets
- Health Utility Measures
- Rett Syndrome
- Immune Dysregulation
- Arginine Methylation
- Protein Arginine Methyltransferases
- Antithrombotic Therapy
- Pancreatic Cancer
- Defensive Medicine
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Antisense Oligonucleotides23▲ 215×2 topics
- SMN122▲ 793×1 topic
- Spinal Muscular Atrophy22▲ 793×1 topic
- Cancer Progression9▲ 33×2 topics
- RNA methylation9▲ 95×1 topic
- m6A-seq9▲ 95×1 topic
- Genetic Mutations8▲ 12×7 topics
- Inflammation8▲ 2.6×15 topics
- Gene Therapy6▲ 18×4 topics
- Epidemiology6▲ 1.17×27 topics
- Quality of Life6▲ 3.4×9 topics
- Hemostasis5▲ 27×3 topics
- Prophylaxis5▲ 29×2 topics
- Thrombosis5▲ 18×5 topics
- Genome Engineering5▲ 65×1 topic
- RNA-Guided5▲ 65×1 topic
- Inhibitors4▲ 51×2 topics
- Factor VIII4▲ 206×1 topic
- Hemophilia4▲ 206×1 topic
- Cancer4▲ 2.3×8 topics
- Transcriptional Regulation4▲ 13×3 topics
- Immune Thrombocytopenic Purpura4▲ 77×1 topic
- Platelets4▲ 47×1 topic
- Cost-effectiveness Analysis3▲ 35×1 topic
- Health Utility Measures3▲ 35×1 topic
- Fragile X Syndrome3▲ 83×1 topic
- Rett Syndrome3▲ 83×1 topic
- Epigenetic Regulation3▲ 10×2 topics
- Immune Dysregulation3▲ 28×1 topic
- Primary Immunodeficiency3▲ 57×1 topic
- Arginine Methylation3▲ 64×1 topic
- Cell Proliferation3▲ 23×2 topics
- Protein Arginine Methyltransferases3▲ 64×1 topic
- Prenatal Diagnosis2▲ 10.0×3 topics
- Antithrombotic Therapy2▲ 15×2 topics
- Anemia2▲ 12×3 topics
- Pancreatic Cancer2▲ 11×2 topics
- Rituximab2▲ 8.4×3 topics
- Defensive Medicine2▲ 37×1 topic
- Healthcare Quality2▲ 11×2 topics
Which research topics does Baxalta (United States) publish most on?
By volume in 2022–2025: Genetics and Neurodevelopmental Disorders, Child Nutrition and Feeding Issues, Aluminum toxicity and tolerance in plants and animals and Coagulation, Bradykinin, Polyphosphates, and Angioedema.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Genetics and Neurodevelopmental Disorders Genetics 0 works
- 2 Child Nutrition and Feeding Issues Psychiatry and Mental health 0 works
- 3 Aluminum toxicity and tolerance in plants and animals Plant Science 0 works
- 4 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 0 works
- 5 Trace Elements in Health Nutrition and Dietetics 0 works
- 6 Art Therapy and Mental Health Conservation 0 works
- 7 Community Development and Social Impact Finance 0 works
- 8 Telemedicine and Telehealth Implementation Public Health, Environmental and Occupational Health 0 works
- 9 Heavy Metal Exposure and Toxicity Health, Toxicology and Mutagenesis 0 works
- 10 Platelet Disorders and Treatments Hematology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Baxalta (United States)'s research output changed?
Output in 2018–2022 was 102% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.